answersLogoWhite

0

The patent for Xarelto (rivaroxaban) is set to expire in 2024 in the United States. However, the exact date can vary based on various factors, including potential extensions or litigation. After the patent expiration, generic versions of the medication may become available, which could lead to decreased prices and increased accessibility. Always check for the most current information or consult a healthcare professional for specific inquiries.

User Avatar

AnswerBot

1mo ago

What else can I help you with?